Literature DB >> 19088926

Intention to treat survival following liver transplantation for hepatocellular carcinoma within a donor service area.

Kevin P Charpentier1, Yee Lee Cheah, Jason T Machan, Tom Miner, Paul Morrissey, Anthony Monaco.   

Abstract

BACKGROUND: This study aimed to assess the impact of wait times on patient survival following liver transplantation for hepatocellular carcinoma (HCC) in a single donor service area. PATIENTS AND METHODS: Patients listed in the New England Organ Bank (NEOB) from 1996 to 2005 for liver transplantation with a diagnosis of HCC were identified from the United Network for Organ Sharing database. The following data were extracted: date of listing, date removed from the wait list, indication for wait list removal, patient death and date of last known follow-up. Kaplan-Meier survival estimates were calculated from the time of listing for transplant (intention to treat liver transplant survival, ITT OLT) and compared to those calculated from the date of transplant (liver transplant, OLT).
RESULTS: There were 63 new registrations to the transplant list during the study period. Sixty-one patients were removed from the waiting list: transplanted 41 (65%), death seven (11%), candidate condition deteriorated/too sick to transplant eight (13%), medically unsuitable one (2%), other one (2%), transferred to another center two (3%), and transplanted at another center one (2%). Three-year survival following liver transplantation for primary liver cancer was 85%. When the results were analyzed using an intention to treat analysis there was a 10-20% decrease in survival rate at every time point due to wait list drop-out.
CONCLUSION: Wait list drop-out adversely affects liver transplant survival in transplant centers served by the NEOB. These data should be considered when recommending transplant versus resection as first line therapy for stage I or II HCC in our region.

Entities:  

Keywords:  hepatocelullar carcinoma; liver; transplant

Year:  2008        PMID: 19088926      PMCID: PMC2597314          DOI: 10.1080/13651820802392320

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  13 in total

1.  Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria.

Authors:  U Cillo; A Vitale; F Grigoletto; E Gringeri; F D'Amico; M Valmasoni; A Brolese; G Zanus; N Srsen; A Carraro; P Burra; F Farinati; P Angeli; D F D'Amico
Journal:  Am J Transplant       Date:  2007-04       Impact factor: 8.086

2.  Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.

Authors:  Carlos Margarit; Alfredo Escartín; Lluis Castells; Víctor Vargas; Elena Allende; Itxarone Bilbao
Journal:  Liver Transpl       Date:  2005-10       Impact factor: 5.799

3.  Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma.

Authors:  Umberto Cillo; Alessandro Vitale; Alberto Brolese; Giacomo Zanus; Daniele Neri; Michele Valmasoni; Pasquale Bonsignore; Francesco Grigoletto; Patrizia Burra; Fabio Farinati; Davide Francesco D'Amico
Journal:  J Surg Oncol       Date:  2007-03-01       Impact factor: 3.454

4.  Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.

Authors:  J M Llovet; J Fuster; J Bruix
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

5.  An analysis of 412 cases of hepatocellular carcinoma at a Western center.

Authors:  Y Fong; R L Sun; W Jarnagin; L H Blumgart
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

6.  Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.

Authors:  Maurizio Pompili; Vincenzo Giorgio Mirante; Gianfranco Rondinara; Luigi Rainero Fassati; Fabio Piscaglia; Salvatore Agnes; Marcello Covino; Matteo Ravaioli; Stefano Fagiuoli; Giovanni Gasbarrini; Gian Ludovico Rapaccini
Journal:  Liver Transpl       Date:  2005-09       Impact factor: 5.799

7.  Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study.

Authors:  Vincenzo Mazzaferro; Carlo Battiston; Stefano Perrone; Andrea Pulvirenti; Enrico Regalia; Raffaele Romito; Dario Sarli; Marcello Schiavo; Francesco Garbagnati; Alfonso Marchianò; Carlo Spreafico; Tiziana Camerini; Luigi Mariani; Rosalba Miceli; Salvatore Andreola
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

8.  Liver transplantation for hepatocellular carcinoma in New Zealand: a prospective intent-to-treat analysis.

Authors:  Yuhji Marui; John McCall; Edward Gane; Andrew Holden; David Duncan; Mee-Ling Yeong; Kai Chow; Stephen Munn
Journal:  N Z Med J       Date:  2005-06-24

Review 9.  Hepatoma--resection or transplantation.

Authors:  Christoph E Broelsch; Andrea Frilling; Massimo Malago
Journal:  Surg Clin North Am       Date:  2004-04       Impact factor: 2.741

10.  Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.

Authors:  Francis Y Yao; Nathan M Bass; Bev Nikolai; Timothy J Davern; Robert Kerlan; Victor Wu; Nancy L Ascher; John P Roberts
Journal:  Liver Transpl       Date:  2002-10       Impact factor: 5.799

View more
  5 in total

1.  Barriers to Care in Chinese Immigrants with Hepatocellular Carcinoma: A Focus Group Study in New York City.

Authors:  Umut Sarpel; Xiaoxiao Huang; Charlotte Austin; Francesca Gany
Journal:  J Community Health       Date:  2018-12

2.  Presentation and outcomes of hepatocellular carcinoma patients at a western centre.

Authors:  Krit Kitisin; Vignesh Packiam; Jennifer Steel; Abhinav Humar; T Clark Gamblin; David A Geller; J Wallis Marsh; Allan Tsung
Journal:  HPB (Oxford)       Date:  2011-08-11       Impact factor: 3.647

3.  Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation.

Authors:  Mariya L Samoylova; Jennifer L Dodge; Francis Y Yao; John Paul Roberts
Journal:  Liver Transpl       Date:  2014-07-03       Impact factor: 5.799

Review 4.  Liver transplantation for hepatocellular carcinoma: an appraisal of current controversies.

Authors:  Yee Lee Cheah; Pierce K H Chow
Journal:  Liver Cancer       Date:  2012-11       Impact factor: 11.740

5.  Pulmonary metastases from primary hepatocellular carcinoma in a 26-year-old patient: a case report.

Authors:  Carla Assed; Edson Marchiori; Gláucia Zanetti; Claudia Mauro Mano; Branca Sarcinelli-Luz; Flávia Gavinho Vianna; Juliana França Carvalho; Isabella Guedes Santos; Alair Augusto Santos; Alberto Domingues Vianna
Journal:  Cases J       Date:  2009-08-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.